Moving Past Anti-VEGF: Novel Therapies for Treating Diabetic Retinopathy
about
Danhong Huayu Koufuye Prevents Diabetic Retinopathy in Streptozotocin-Induced Diabetic Rats via Antioxidation and Anti-Inflammation.A Review: Proteomics in Retinal Artery Occlusion, Retinal Vein Occlusion, Diabetic Retinopathy and Acquired Macular Disorders.Oxidative stress and diabetic retinopathy: development and treatment.Many Faces of Renin-angiotensin System - Focus on Eye.Small GTPase ARF6 controls VEGFR2 trafficking and signaling in diabetic retinopathy.Effects of Intravitreal Aflibercept on Galectin-1 and Vascular Endothelial Growth Factor-A Plasma Levels in Patients with Diabetic Retinopathy.Vascular Endothelial Growth Factor-A Exerts Diverse Cellular Effects via Small G Proteins, Rho and Rap.A LATS biosensor screen identifies VEGFR as a regulator of the Hippo pathway in angiogenesis.Anti-inflammatory cytokine and angiogenic factors levels in vitreous samples of diabetic retinopathy patients.Gαi1 and Gαi3mediate VEGF-induced VEGFR2 endocytosis, signaling and angiogenesisPathophysiology of Diabetic Retinopathy: The Old and the New
P2860
Q33791268-2B02A43F-2A0B-4195-BFEA-B129B491CD95Q39269575-359EECA7-037E-4819-AA14-46C84DC1609AQ39269643-3C030E97-646A-4C1D-A2D5-4146E0508BF3Q41015495-E209933E-941E-4E2D-8DFA-2A781155E11CQ48623673-AD5945A9-9696-4E0A-B3BB-1DB46C894F0DQ49667627-97F48C96-F806-4806-955E-FC17C7126A79Q52719147-9720CB53-3FA1-4DC6-955D-7DB6D5936A57Q54982188-7DC4B7C9-A4F4-4437-BE63-1DE861F86D54Q55293840-EAC78467-C219-4EB0-B415-287CF7478236Q57116127-884A2D5C-B690-4AEC-90CE-48536D3F67D2Q58591190-4F23952A-79E0-448A-995F-77F7D6B3A29D
P2860
Moving Past Anti-VEGF: Novel Therapies for Treating Diabetic Retinopathy
description
2016 nî lūn-bûn
@nan
2016 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Moving Past Anti-VEGF: Novel Therapies for Treating Diabetic Retinopathy
@ast
Moving Past Anti-VEGF: Novel Therapies for Treating Diabetic Retinopathy
@en
Moving Past Anti-VEGF: Novel Therapies for Treating Diabetic Retinopathy
@nl
type
label
Moving Past Anti-VEGF: Novel Therapies for Treating Diabetic Retinopathy
@ast
Moving Past Anti-VEGF: Novel Therapies for Treating Diabetic Retinopathy
@en
Moving Past Anti-VEGF: Novel Therapies for Treating Diabetic Retinopathy
@nl
prefLabel
Moving Past Anti-VEGF: Novel Therapies for Treating Diabetic Retinopathy
@ast
Moving Past Anti-VEGF: Novel Therapies for Treating Diabetic Retinopathy
@en
Moving Past Anti-VEGF: Novel Therapies for Treating Diabetic Retinopathy
@nl
P2860
P921
P3181
P356
P1476
Moving Past Anti-VEGF: Novel Therapies for Treating Diabetic Retinopathy
@en
P2093
David Antonetti
Mark Bolinger
P2860
P3181
P356
10.3390/IJMS17091498
P407
P5008
P577
2016-09-07T00:00:00Z